Nexium Dominates Top 2 Rankings in HP Market 2 Months in a Row: RepTrack Dec. Survey

According to a RepTrack Survey conducted by ANTERIO Inc. in December (December 5-26), Daiichi Sankyo’s proton pump inhibitor (PPI) Nexium (esomeprazole), which was launched in September, rose to the No. 1 position in the HP (medical institutions with 100 or...read more